LifeMD, Inc.

NasdaqGM LFMD

LifeMD, Inc. Price to Earnings Ratio (P/E) on February 05, 2025: -11.56

LifeMD, Inc. Price to Earnings Ratio (P/E) is -11.56 on February 05, 2025, a -44.48% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.
  • LifeMD, Inc. 52-week high Price to Earnings Ratio (P/E) is -7.46 on October 31, 2024, which is 35.48% above the current Price to Earnings Ratio (P/E).
  • LifeMD, Inc. 52-week low Price to Earnings Ratio (P/E) is -21.54 on May 06, 2024, which is -86.36% below the current Price to Earnings Ratio (P/E).
  • LifeMD, Inc. average Price to Earnings Ratio (P/E) for the last 52 weeks is -11.56.
Key data
Date Price to Earnings Ratio (P/E) Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield
Market news
Loading...
SV Wall Street
NasdaqGM: LFMD

LifeMD, Inc.

CEO Mr. Justin Schreiber
IPO Date Jan. 29, 2008
Location United States
Headquarters 236 Fifth Avenue
Employees 207
Sector Healthcare
Industries
Description

LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for care across various indications, including concierge care, men's sexual health, dermatology, and others in the United States. The company provides ShapiroMD, a telehealth platform brand that offers access to virtual medical treatment, prescription medications, patented-doctor formulated OTC products, and an FDA approved medical device for male and female hair loss, and female specific topical compounded medications for hair loss; RexMD, a men's telehealth brand that offers virtual medical treatment from licensed providers for a variety of men's health needs; LifeMD Primary Care, a personalized subscription-based virtual primary care platform that provides patients with primary care, urgent care, and chronic care needs, as well as .offers a mobile first platform that incorporates virtual consultations and treatment, prescription medications, diagnostics, and imaging; Cleared, a telehealth brand that provides personalized treatments for allergy, asthma, and immunology; and Nava MD, a female-oriented tele-dermatology and skincare brand that offers virtual medical treatment from dermatologists and other providers. It also offers PDFSimpli, an online software-as-a-service platform that allows users to create, edit, convert, sign, and share PDF documents. LifeMD sells its products directly to consumers and through e-commerce platforms, as well as through third party partner channels. The company was formerly known as Conversion Labs, Inc. and changed its name to LifeMD, Inc. in February 2021. LifeMD, Inc. was founded in 1994 and is headquartered in New York, New York.

Similar companies

STRM

Streamline Health Solutions, Inc.

USD 3.78

-9.13%

PRVA

Privia Health Group, Inc.

USD 23.38

0.91%

EVH

Evolent Health, Inc.

USD 10.37

1.17%

NRC

National Research Corporation

USD 16.90

3.81%

HSTM

HealthStream, Inc.

USD 33.39

0.18%

FORA

Forian Inc.

USD 2.44

3.39%

StockViz Staff

February 7, 2025

Any question? Send us an email